NOLAN SEAN P. received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001415889-25-000599
+1.78M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.78M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+892.50K
Price / share
—
Trade value
—
% of position
75.3%
1/2/2025
1.19M→2.08M
Total
Net shares
+892.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | A · Award | +892.50K | — | — | 75.3% | 1.19M | 2.08M |
| Total | +892.50K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
892.50K shares
Shares
+892.50K
Strike price
1.85
Held after
892.50K
Exercisable
—
1/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock892.50K shares | 1/2/2025 | A · Award | +892.50K | 1.85 | — | 892.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.54M
Total
1.54M indirect1.54M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.54M | Indirect |
| Total | 1.54M | 1.54M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported